PDG15 ECONOMIC ASSESSMENT OF SWITCHING FROM DIPEPTIDYL PEPTIDASE-4 INHIBITORS TO SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS OR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST USING REAL-WORLD DATA

May 1, 2020, 00:00
10.1016/j.jval.2020.04.305
https://www.valueinhealthjournal.com/article/S1098-3015(20)30493-9/fulltext
Title : PDG15 ECONOMIC ASSESSMENT OF SWITCHING FROM DIPEPTIDYL PEPTIDASE-4 INHIBITORS TO SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS OR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST USING REAL-WORLD DATA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30493-9&doi=10.1016/j.jval.2020.04.305
First page :
Section Title :
Open access? : No
Section Order : 10169
Categories :
Tags :
Regions :
ViH Article Tags :